
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17890926
[patent_doc_number] => 11453883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Display systems for proteins of interest
[patent_app_type] => utility
[patent_app_number] => 16/375894
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 15754
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375894 | Display systems for proteins of interest | Apr 4, 2019 | Issued |
Array
(
[id] => 14893975
[patent_doc_number] => 20190290753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS
[patent_app_type] => utility
[patent_app_number] => 16/375935
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375935 | COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS | Apr 4, 2019 | Abandoned |
Array
(
[id] => 16581475
[patent_doc_number] => 20210015877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => LACTOBACILLUS FERMENTUM FOR TREATING FRUCTOSE-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/040019
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040019 | None | Mar 11, 2019 | Issued |
Array
(
[id] => 16413304
[patent_doc_number] => 10821166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Isolated polypeptide of the toxin A and toxin B proteins of
[patent_app_type] => utility
[patent_app_number] => 16/295031
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 30177
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295031 | Isolated polypeptide of the toxin A and toxin B proteins of | Mar 6, 2019 | Issued |
Array
(
[id] => 16581473
[patent_doc_number] => 20210015875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => NANOVESICLES DERIVED FROM ENHYDROBACTER BACTERIA, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/978562
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978562 | Nanovesicles derived from enhydrobacter bacteria, and use thereof | Mar 4, 2019 | Issued |
Array
(
[id] => 17648504
[patent_doc_number] => 11351207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Use of direct-fed microbials in preventing and/or treating
[patent_app_type] => utility
[patent_app_number] => 16/977514
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10033
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977514 | Use of direct-fed microbials in preventing and/or treating | Mar 3, 2019 | Issued |
Array
(
[id] => 15175437
[patent_doc_number] => 20190358310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METHOD FOR REDUCING SKATOLE AND/OR INDOLE IN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/283946
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283946 | Method for reducing skatole and/or indole in animals | Feb 24, 2019 | Issued |
Array
(
[id] => 18994944
[patent_doc_number] => 11911764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => System and method for cell imaging, analysis and measurement
[patent_app_type] => utility
[patent_app_number] => 16/963233
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8095
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963233 | System and method for cell imaging, analysis and measurement | Feb 20, 2019 | Issued |
Array
(
[id] => 14406787
[patent_doc_number] => 20190169237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/274935
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274935 | MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF | Feb 12, 2019 | Abandoned |
Array
(
[id] => 14682385
[patent_doc_number] => 20190240307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => SYNTHETIC IMMUNOGENS FOR PROPHYLAXIS OR TREATMENT OF TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/272203
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/272203 | Synthetic immunogens for prophylaxis or treatment of tuberculosis | Feb 10, 2019 | Issued |
Array
(
[id] => 16511571
[patent_doc_number] => 20200390828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => LIPOPOLYSACCHARIDE-REGULATED ENTERIC BACTERIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/968376
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968376 | Lipopolysaccharide-regulated enteric bacteria and use thereof | Feb 7, 2019 | Issued |
Array
(
[id] => 14338915
[patent_doc_number] => 20190151430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/269370
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269370 | Adjuvanting meningococcal factor H binding protein | Feb 5, 2019 | Issued |
Array
(
[id] => 16673103
[patent_doc_number] => 20210061866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => SEA LICE ANTIGENS AND VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/963645
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963645 | SEA LICE ANTIGENS AND VACCINES | Jan 24, 2019 | Abandoned |
Array
(
[id] => 14273781
[patent_doc_number] => 20190134175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => EHRLICHIAL INVASIN FOR IMMUNIZTION, DIAGNOSIS, AND CELL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/245904
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245904 | None | Jan 10, 2019 | Issued |
Array
(
[id] => 15191287
[patent_doc_number] => 10493114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Lactobacillus-based
[patent_app_type] => utility
[patent_app_number] => 16/236096
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25100
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16236096
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/236096 | Lactobacillus-based | Dec 27, 2018 | Issued |
Array
(
[id] => 17655440
[patent_doc_number] => 20220175905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => MONOVALENT VACCINE FORMULATION AND A METHOD FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/960865
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960865 | Monovalent vaccine formulation and a method for preparation thereof | Dec 25, 2018 | Issued |
Array
(
[id] => 16485367
[patent_doc_number] => 20200378970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/766497
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766497 | COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS | Dec 18, 2018 | Abandoned |
Array
(
[id] => 16484019
[patent_doc_number] => 20200377620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => CLOSTRIDIUM PERFRINGENS SURFACE GLYCANS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/770275
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770275 | CLOSTRIDIUM PERFRINGENS SURFACE GLYCANS AND USES THEREOF | Dec 18, 2018 | Abandoned |
Array
(
[id] => 16962903
[patent_doc_number] => 20210214402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => IMMUNOGENIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/954306
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954306 | Immunogenic composition | Dec 18, 2018 | Issued |
Array
(
[id] => 16688673
[patent_doc_number] => 20210071149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR
[patent_app_type] => utility
[patent_app_number] => 16/955715
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -102
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955715 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | Dec 18, 2018 | Abandoned |